Our results suggest that EZH2 may exert its oncogenic function partially by silencing tumor-suppressive miRNAs, and further research is required to fully characterize the miRNAs silenced by H3K27me3 in NSCLC. The gene discussed is EZH2; the disease is non-small cell lung carcinoma.